✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹919 Cr.
P/E
30.10

Key Ratios

Market cap
Market cap
919 Cr
PE
PE
30.10
Prom Holding
Prom Holding
39.76 %
ROE (%)
ROE (%)
200
ROCE (%)
ROCE (%)
48.40
Div Yield (%)
Div Yield (%)
-
Sales
Sales
597 Cr
OPM (%)
OPM (%)
12.47 %
Debt to Equity
Debt to Equity
5.21
About
Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 C… Read more
Low
153
52W Range
High
330
  • Wanbury
  • Shivalik Rasayan
  • Sakar Healthcare

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

1 Neutral

Neutral for this company

11 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Wanbury Ltd. Business

Wanbury Limited is a prominent Indian pharmaceutical company ranked among the top 50 in the country. Specializing in API sales globally and domestic formulations, Wanbury has a significant presence in the industry.

Wanbury major competitors are Shivalik Rasayan, Sakar Healthcare, Anuh Pharma, Bharat Parenterals, Kwality Pharma, Lincoln Pharma, Kilitch Drugs(India).
Market Cap of Wanbury is ₹919 Crs.
While the median market cap of its peers are ₹834 Crs.

Wanbury seems to be less financially stable compared to its competitors.
Altman Z score of Wanbury is 3.77 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Mar Jun Sep Dec Dec
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material